Organizing committee invites all participants from all over the world to attend “12th International Virology Summit’’ during June 24-25, 2020 in Rome, Italy.

Virology is a global overview with the Theme: “Research on Viruses and Explore Advances in Clinical Virology” is designed for professionals at all levels and career phases of the virology researchers, microbiologists from around the world, widen professional contact and create new opportunities, including establishing new collaborations. This event will provide an opportunity to build and expand your network with various people and gives chance to make collaboration with other universities and research labs. It also helps you to meet the experts in the relevant field of study. Conduct presentations, distribute information, meet with current and potential scientists, and make a splash with new Virology developments

 Why to attend???

•  Build your professional network.
•  Hear about the latest research.
•  Improve your presentation and communication skills.
•  Get response on an early version of your latest work.
•  Acquire beyond your field or interest.
•  Get opportunity to people to meet you.
•  Know the strengths and weakness of your conferences.
•  Easier to solve the problems and struggles which you go through at work.

Target Audience:

• Scientists
• Young  research  fellows
• Research Scholars
• Residents, Fellows & Post Docs
• Students
• Manufacturing Medical Devices Companies
• Business Executives & Directors
• Virology and Microbiology Associations and Societies
• Advertising Agency Executives
• Industry professionals

Market Growth of Virology:

The global virology market is estimated in 2017 at $1693 million and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is one of the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. North America is expected to retain the top market position over this forecast period.

Globally the Europe is projected to maintain the position as the second largest market. Throughout the forecast period, Europe is estimated to record the highest CAGR, recognized by enhanced healthcare infrastructure, growing affordability of diagnostic tests for viral diseases and facilitated access to diagnostics.

The global viral inactivation market size was valued in 2016 at USD 1.8 billion and is expected to witness a CAGR of 12.5% during these forecast period.

On the basis of diagnosis tests, hepatitis B, Hepatitis C, HIV, Human papillomavirus (HPV), and other tests (like influenza, Ebola, and dengue) are estimated to hold the largest market share globally during the forecast period. Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, Immunomodulators), Interferon’s (Cytokines) are some of the Viral Infection controlling Methods. Immunoprophylaxis therapy and antiviral drugs are the fastest growing market segments in these estimated forecast period.

Virology Market is segmented By Applications into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract & Urinary Tract infections, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections. In the global virology market STDs, Urinary tract infections, and respiratory tract infections are currently dominating as compared to the other application types. Virology Market is segmented By End Users into Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, and Pharmacies.

Best Regards         
Mark Daniel | Program Director        
Euro Virology 2020         
Contact Number: +44-7480-727986
Email: eurovirology@brainstormingmeetings.com
Website: https://virology.conferenceseries.com/europe/